Not So Different: Biosimilars Oncology Roundup for July 2022—Podcast Edition
Season 5, Episode 3, Aug 07, 2022, 11:00 AM
Share
Subscribe
On this episode of Not So Different, we recapped some of the biggest biosimilars news that happened over the past month, including updates on clinical trials for oncology biosimilars as well as a survey on whether patients were given adequate information prior to switching a biosimilar.
Show notes
Written version of the roundup
Phase 3 denosumab trial results
Alvotech’s pharmacokinetics trial for denosumab
Poster from the American Society of Clinical Oncology’s annual meeting
Phase 1 pertuzumab trial
Rituximab studies from the European Hematology Association Congress 2022
Survey on preparing patients and providers for switching to a biosimilar